Health Catalyst, Inc. (NASDAQ:HCAT) Given Average Rating of “Moderate Buy” by Brokerages
Health Catalyst, Inc. (NASDAQ:HCAT – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the ten brokerages that are currently covering the company, MarketBeat reports. Three investment analysts have rated the stock with a hold rating and seven have given a buy rating to the company. The average 1-year price target […]
Health Catalyst, Inc. (NASDAQ:HCAT – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the ten brokerages that are currently covering the company, MarketBeat reports. Three investment analysts have rated the stock with a hold rating and seven have given a buy rating to the company. The average 1-year price target […]
